The Denekamp diadems--a review of Julie's achievements.
Dr Julie Denekamp, DSc, PhD, BSc was present at a symposium held in her honour in Uppsala in February 2001. This article presents some biographical details and summarizes the main features of the scientific work for which she is known in radiobiology applied to cancer treatment, now called Translational Research. Topics include fractionation, proliferation in normal tissues as well as tumours, early versus late reactions, radiosensitizers, vascular attack in tumours, neutrons (and pions), radiosensitizers, radioprotectors, hyperthermia, research methodology, and theoretical modelling.
Fowler
J F
JF
Department of Human Oncology, University of Wisconsin, Madison, USA. jf-fowler@mail.humonc.wisc.edu
D020533:Angiogenesis Inhibitors / Q000266:history / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000266:history* / Q000532:radiotherapy; D019583:Dose Fractionation, Radiation; D049673:History, 20th Century; D006801:Humans; D006979:Hyperthermia, Induced / Q000266:history; D009502:Neutrons / Q000266:history / Q000627:therapeutic use; D018787:Radiation Oncology / Q000266:history* / Q000379:methods; D011838:Radiation-Sensitizing Agents / Q000266:history / Q000627:therapeutic use; D006113:United Kingdom
D020533:Angiogenesis Inhibitors; D011838:Radiation-Sensitizing Agents